PI3Kα inhibitor DFX24 shows antiproliferation and apoptosis of lung cancer cells by inhibiting PI3K/AKT and ERK but promoting EPH receptor B6 (EPHB6) expression [141]. This evidence concerns the gene AKT1 and lung carcinoma.